IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX)

CUSIP: 4525EP101

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
140,994,040
Total 13F shares
48,654,047
Share change
+8,400,095
Total reported value
$25,965,609
Put/Call ratio
25%
Price per share
$0.53
Number of holders
58
Value change
+$3,658,356
Number of buys
23
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 4525EP101?
CUSIP 4525EP101 identifies IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Adage Capital Management, L.P.
13D/G
10%
10,479,337
$8,697,850 +$7,537,012 30 Jun 2025
JANUS HENDERSON GROUP PLC
13D/G
10%
12,016,444
$8,531,675 +$6,622,427 28 Nov 2025
Aberdeen Group plc
13F 13D/G
Company
6.8%
from 13D/G
8,243,941
$7,267,858 30 Sep 2025
Nantahala Capital Management, LLC
13D/G
8.2%
10,378,406
$7,057,316 -$174,188 31 Dec 2025
BVF INC/IL
13F
Company
5.4%
7,652,972
$6,746,860 30 Sep 2025
13F
683 Capital Management, LLC
13D/G
5.9%
7,500,000
$5,100,000 -$2,131,423 31 Dec 2025
Alyeska Investment Group, L.P.
13D/G
6.2%
7,500,000
$5,100,000 -$2,550,000 31 Dec 2025
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
4.4%
3,923,763
$4,473,090 $0 31 Dec 2024
Avidity Partners Management LP
13F
Company
3.3%
4,699,411
$4,143,001 30 Sep 2025
13F
MORGAN STANLEY
13F
Company
2.2%
3,103,122
$2,735,712 30 Sep 2025
13F
Focus Partners Wealth
13F
Company
1.8%
2,581,587
$2,275,927 30 Sep 2025
13F
Laurion Capital Management LP
13F
Company
1.3%
1,882,162
$1,659,314 30 Sep 2025
13F
Soleus Private Equity Fund III, L.P.
13D/G
Soleus Capital Management, L.P.
1.6%
1,580,007
$1,392,934 $0 30 Sep 2025
Soleus Capital Management, L.P.
13F
Company
1.1%
1,580,007
$1,392,934 30 Sep 2025
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.99%
1,398,600
$1,233,006 30 Sep 2025
13F
RTW INVESTMENTS, LP
13D/G
1.1%
1,026,762
$1,170,509 $0 31 Mar 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.73%
1,033,772
$911,653 30 Sep 2025
13F
Ikarian Capital, LLC
13F
Company
0.65%
914,170
$805,932 30 Sep 2025
13F
BlackRock, Inc.
13F
Company
0.51%
725,743
$639,815 30 Sep 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.38%
535,083
$471,729 30 Sep 2025
13F
MARSHALL WACE, LLP
13F
Company
0.38%
533,515
$469,492 30 Sep 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.38%
530,470
$467,662 30 Sep 2025
13F
Daniel Vitt
3/4/5
CEO and Director, Director
mixed-class rows
2,809,877
mixed-class rows
$352,548 +$11,550 16 Jul 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.28%
391,653
$345,281 30 Sep 2025
13F
STATE STREET CORP
13F
Company
0.24%
331,945
$292,643 30 Sep 2025
13F
Squarepoint Ops LLC
13F
Company
0.19%
271,574
$239,420 30 Sep 2025
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.17%
240,873
$212,354 30 Sep 2025
13F
NORTHERN TRUST CORP
13F
Company
0.15%
211,347
$186,323 30 Sep 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.14%
195,331
$172,204 30 Sep 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.14%
192,923
$170,000 30 Sep 2025
13F
Richard A. Rudick
3/4/5
Director
mixed-class rows
480,375
mixed-class rows
$161,055 +$100,024 05 Jun 2025
Exome Asset Management LLC
13F
Company
0.12%
173,900
$153,310 30 Sep 2025
13F
Joerg Neermann
3/4/5
Director
mixed-class rows
450,000
mixed-class rows
$152,000 +$76,700 05 Jun 2025
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.08%
115,000
$101,384 30 Sep 2025
13F
Virtu Financial LLC
13F
Company
0.08%
112,287
$99,000 30 Sep 2025
13F
Strategies Wealth Advisors, LLC
13F
Company
0.07%
100,000
$88,160 30 Sep 2025
13F
HB Wealth Management, LLC
13F
Company
0.06%
91,450
$80,622 30 Sep 2025
13F
Glenn Whaley
3/4/5
Chief Financial Officer
mixed-class rows
879,010
mixed-class rows
$68,079 +$32,076 16 Jul 2025
TWO SIGMA INVESTMENTS, LP
13F
Company
0.04%
58,681
$51,733 30 Sep 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.04%
54,400
$48,000 30 Sep 2025
13F
LPL Financial LLC
13F
Company
0.04%
53,050
$46,769 30 Sep 2025
13F
UBS Group AG
13F
Company
0.03%
38,687
$34,122 30 Sep 2025
13F
Creative Planning
13F
Company
0.02%
35,000
$30,856 30 Sep 2025
13F
Duane Nash
3/4/5
Executive Chairman, Director
mixed-class rows
921,032
mixed-class rows
$30,075 +$16,694 16 Jul 2025
Qube Research & Technologies Ltd
13F
Company
0.02%
32,669
$28,801 30 Sep 2025
13F
Bank of New York Mellon Corp
13F
Company
0.02%
30,456
$26,850 30 Sep 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
25,000
$22,040 30 Sep 2025
13F
Marex Group plc
13F
Company
0.02%
22,500
$19,836 30 Sep 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
20,707
$18,255 30 Sep 2025
13F
Ring Mountain Capital, LLC
13F
Company
0.01%
18,039
$16,000 30 Sep 2025
13F

Institutional Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q4 2025

As of 31 Dec 2025, IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) was held by 58 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,654,047 shares. The largest 10 holders included Aberdeen Group plc, BVF INC/IL, VANGUARD GROUP INC, Avidity Partners Management LP, Nantahala Capital Management, LLC, Laurion Capital Management LP, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 58 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
61
Q4 2025 holders
58
Holder diff
-3
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 Value $ Q4 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.